Categories: Business

Woodside Energy’s Scarborough Offshore Facility and Trunkline (Operations) Environment Plan

PERTH, Australia–(BUSINESS WIRE)–Woodside welcomes the Federal Court’s decision confirming the validity of the National Offshore Petroleum Safety and Environmental Management Authority’s acceptance of the Scarborough Offshore Facility and Trunkline (Operations) Environment Plan (Scarborough Operations EP).

- Advertisement -

The Scarborough Operations EP was the final Commonwealth environmental approval required for Woodside to connect, commission and operate the Scarborough floating production unit.

- Advertisement -

Woodside CEO Meg O’Neill acknowledged the decision and highlighted the project’s progress and impact.

- Advertisement -

“This outcome reinforces confidence in progressing the Scarborough Energy Project, which is generating thousands of jobs during the construction phase and creating significant supply chain opportunities. The project is expected to contribute more than A$50 billion in direct and indirect taxes to Australia’s economy.

- Advertisement -

“Scarborough is expected to be one of the lowest carbon intensity sources of LNG delivered into north Asian markets, providing reliable energy to the region while also supporting local energy security through critical domestic gas supply.”

- Advertisement -

About the Scarborough Energy Project

- Advertisement -

The Scarborough Energy Project comprises the Scarborough gas field, construction of Pluto Train 2, modifications to the existing Pluto Train 1 and the Integrated Remote Operations Centre.

- Advertisement -

It is set to produce up to 8 million tonnes of LNG per year and contribute up to 225 terajoules per day of domestic gas supply into the Western Australian market.

- Advertisement -

The Scarborough Energy Project was 86% complete as at 30 June 2025 (excluding Pluto Train 1 modifications) and is targeting first LNG cargo in the second half of 2026.

- Advertisement -

Contacts

- Advertisement -

Media contacts

- Advertisement -

Australia
Christine Abbott

M: +61 484 112 469

E: christine.abbott@woodside.com

- Advertisement -
Business Wire

Recent Posts

Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes

LEHI, Utah, Oct. 23, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies…

21 minutes ago

ArisGlobal Receives Frost & Sullivan’s 2025 Global Intelligent MedDRA Coding New Product Innovation Recognition for AI Leadership and Customer Impact

ArisGlobal is honored for its technological breakthrough in intelligent MedDRA coding that enhances accuracy, accelerates…

21 minutes ago

Global Drug Delivery Systems (DDS) Market Transforms Amid New Pharma Demands

FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Alira Health today released its 2025 Global…

2 hours ago

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies

The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed with no safety…

2 hours ago

Beijing Irrigation Expo 2026: A Global Summit for Smart Agriculture and Technology Exploration

BEIJING, Oct. 23, 2025 /PRNewswire/ -- Scheduled for March 30 to April 1, 2026, at…

5 hours ago

Dun & Bradstreet Honours Public Sector Excellence at the PSU & Government Summit 2025

MUMBAI, India, Oct. 23, 2025 /PRNewswire/ -- Dun & Bradstreet, a leading global provider of…

5 hours ago